Are GLP-1 Injections Safe?
Semaglutide-based medications like Ozempic and Wegovy are increasingly used worldwide for weight management and glycaemic control. While they can deliver meaningful weight loss, it’s essential to understand safety considerations, side effects, and rare risks before starting treatment.
How Semaglutide Works and Why Side Effects Occur
Semaglutide is a GLP-1 receptor agonist — it mimics a gut hormone that slows stomach emptying, increases feelings of fullness, and helps regulate appetite. These mechanisms support weight loss but also explain many of the common side effects that affect the gastrointestinal tract and other systems.
Common Side Effects — What Most People Experience
Most users of Ozempic or Wegovy experience mild to moderate side effects, particularly when they first start or when doses are increased. These are usually temporary.
Typical common effects include:
- Nausea and Vomiting
- Diarrhoea or Constipation
- Injection Site Reactions (redness, itching, mild pain)
- Headache and Fatigue
- Injection Site Reactions (redness, itching, mild pain)
These symptoms often lessen over a few weeks as the body adjusts to the medication.
Less Common But Important Risks
While uncommon, some side effects are more serious and require prompt medical attention. These include:
Pancreatitis (Inflammation of the Pancreas)
- Symptoms: Severe abdominal pain, nausea, vomiting
- A large observational study found that GLP-1 medications (including Ozempic and Wegovy) may carry a higher risk of pancreatitis.
Gallbladder Disease & Gallstones
- Rapid weight loss and altered gallbladder motility can increase the risk of gallstones.
Kidney Function Changes
- Dehydration from nausea or vomiting can strain kidney function in susceptible individuals.
Metabolic Effects (e.g., Low Blood Sugar)
- Especially in people with diabetes, semaglutide may interact with other glucose-lowering medicines.
Rare & Emerging Safety Signals
Although rare, ongoing safety monitoring continues to identify possible associations and warrant caution:
- Thyroid Tumour Signals in Animal Studies: Semaglutide class drugs showed thyroid C-cell tumours in rodent studies, but this has not been verified in humans.
- Psychological & Eating Behaviour Changes: Early reports raise concerns about potential impacts on mood or disordered eating patterns in some users. (emerging global concerns)
- Pancreatitis Reports from Regulators: Recent drug safety advisories emphasise vigilance for severe abdominal symptoms due to a small but documented risk of acute pancreatitis with GLP-1 drugs.
Rare events underscore why medical supervision and regular monitoring are crucial during treatment.
Ozempic Face
Who Should Be Cautious or Avoid Semaglutide
Semaglutide injections may not be suitable for everyone. Discuss with a clinician if you have:
- A history of pancreatitis or gallbladder disease
- Severe gastrointestinal disorders
- Personal or family history of medullary thyroid cancer or MEN2
- Pregnant or breastfeeding (use is generally discouraged)
A qualified healthcare provider can assess your individual risk and help you decide if this therapy is appropriate.
Tips to Minimise Side Effects
To improve tolerance and safety:
- Start with a low dose and slowly titrate under clinician guidance
- Maintain hydration and eat smaller, regular meals
- Communicate promptly with your doctor about any new or worsening symptoms
- Combine medical therapy with a balanced diet and physical activity for sustainable results
Contact Us
Book An Appointment Now
Take the first step toward a healthier, more confident you. Our medical team is ready to answer your questions and guide you through safe, personalised weight-loss options. Reach out today to schedule a consultation or speak with our care specialists.